Skip to main content
logo
Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.630
-0.010 (-0.61%)
At close: Mar 6, 2026, 4:00 PM EST
1.670
+0.040 (2.45%)
After-hours: Mar 6, 2026, 7:58 PM EST

Palisade Bio Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
242.88M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023250.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 201915.39K-244.61K-94.08%
Dec 31, 2018260.00K--
Dec 31, 2017260.00K243.75K1,500.39%
Dec 31, 201616.25K5.83K55.96%
Dec 31, 201510.42K-8.42K-44.69%
Dec 31, 201418.83K-91.17K-82.88%
Dec 31, 2013110.00K-297.71K-73.02%
Dec 31, 2012407.71K17.08K4.37%
Dec 31, 2011390.63K-342.81K-46.74%
Dec 31, 2010733.44K--
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007306.06K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Keros Therapeutics244.06M
Prelude Therapeutics10.50M
Ovid Therapeutics6.61M
Camp4 Therapeutics3.50M
Orchestra BioMed Holdings2.82M
Silence Therapeutics559.00K
Inhibikase Therapeutics1.00
Revenue Rankings

PALI News

More News